Skip to content

Author

N. Shah

We have 2 of 33 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Antibody-drug conjugates in solid tumors: Efficacy, challenges, and opportunities.

Antibody-drug conjugates (ADCs) have become an increasingly important component of the therapeutic landscape of many solid tumors. Currently, there are eight ADCs approved for solid tumors, with hundreds being developed and in clinical trials. Initially being approved in the advanced or metastatic settings, ADCs are al...

N. Shah, F. Meric-Bernstam · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.